aod9604 - lipotropin AOD-9604 | CAS#221231-10-3 AOD-9604 Vial — Lyophilized, HPLC

Third-party tested: Every batch ships with a Certificate of Analysis (COA) confirming purity and composition

Standard initial therapy for patients without neurological involvement is 1000 mcg intramuscularly (i.m.) three times a week for 2 weeks

For FDA-approved tirzepatide, LillyDirect Zepbound vials at ~$499/mo self-pay is the manufacturer-direct benchmark

Others might look to enhance cellular energy pathways further with compounds like Mots-c or NAD+ , both known for their roles in mitochondrial function and cellular health

Inhibition of Lipogenesis (The Pull): It inhibits Lipoprotein Lipase (LPL) and Acetyl-CoA Carboxylase (ACC), preventing the uptake of dietary fat and the synthesis of new triglycerides